Loading clinical trials...
Loading clinical trials...
This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant women in Tanzania would slow disease progression and enhance their overall health.
In this study, we sought to examine whether the administration of multivitamins excluding vitamin A, multivitamins including vitamin A, or vitamin A alone would reduce the risk of perinatal transmission of HIV and slow the rate of disease progression in a group of pregnant HIV infected women. We also examined the efficacy of the supplements on pregnancy outcomes, and risks of maternal and child morbidity and wasting.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Harvard School of Public Health
Boston, Massachusetts, United States
Start Date
April 1, 1995
Primary Completion Date
August 1, 2003
Completion Date
August 1, 2003
Last Updated
November 11, 2010
1,085
ACTUAL participants
Vitamin A + Beta Carotene
DIETARY_SUPPLEMENT
Multivitamins
DIETARY_SUPPLEMENT
Placebo
OTHER
Lead Sponsor
Harvard School of Public Health (HSPH)
Collaborators
NCT04142047
NCT06694805
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330